{"product_id":"totallyplc-bcg-matrix","title":"Totally Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Totally BCG Matrix preview highlights where key offerings may fall—Stars, Cash Cows, Dogs, or Question Marks—and teases strategic implications; purchase the full BCG Matrix for a complete, data-driven quadrant map, specific recommendations, and clear capital-allocation guidance you can act on today.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Urgent Care (IUC)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIntegrated Urgent Care (IUC) stays a Star as NHS demand for 111 and GP out-of-hours rose ~12% year-on-year to Q3 2025, keeping Totally’s revenue from IUC at about £320m in FY 2024–25 with double-digit CAGR; Totally holds dominant shares in several regions (30–45%), forcing ongoing reinvestment to handle ~5.6m annual calls and rising clinical staffing costs (~+9% wage inflation in 2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Triage Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTotally's Digital Health Triage Solutions sit in the Stars quadrant after growing revenue 68% YoY to $92M in 2025 as digital-first care adoption rose to 42% of outpatient interactions in the US (2024 KFF data).\u003c\/p\u003e\n\u003cp\u003eRapid uptake cut average clinic visits 18% and emergency visits 9% in pilot networks, easing physical pressure and boosting lifetime user value to $1,400.\u003c\/p\u003e\n\u003cp\u003eR\u0026amp;D spend rose to 22% of revenue ($20M in 2025) to fund AI clinical-pathways and regulatory filings, a heavy but justifiable capital allocation given a projected market share climb from 3% to 9% by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommunity Diagnostics Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe UK government funded over 160 community diagnostic centres by March 2025, and Totally has secured contracts for 28 sites, positioning it as a market leader in local screening and testing services.\u003c\/p\u003e\n\u003cp\u003eDemand rose 42% between 2021–2024 to clear post‑COVID backlogs, making outsourced elective diagnostics a fast‑growing revenue stream; Totally’s diagnostics revenue grew 38% in FY2024 to £46.2m.\u003c\/p\u003e\n\u003cp\u003eSustained capital expenditure of ~£12–15m over 2025–2027 is needed to buy MRI\/CT scanners and preserve service leadership and average wait‑time targets under NHS contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUrgent Treatment Centres (UTCs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTotally's Urgent Treatment Centres (UTCs) are high-performing units easing A\u0026amp;E load, delivering \u0026gt;20% faster patient flow and handling ~150–300 cases\/day per site, via contracts with 18 NHS trusts signed in 2024–25.\u003c\/p\u003e\n\u003cp\u003eUTCs are in high-growth phase as NHS outsourcing rises 12% yr\/yr; Totally grew UTC revenue 38% in FY2024 to £74m, with strong market share but reliant on continued operational funding to hit 95%+ KPI targets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eThroughput: 150–300 pts\/day\u003c\/li\u003e\n\u003cli\u003eContracts: 18 NHS trusts (2024–25)\u003c\/li\u003e\n\u003cli\u003eRevenue: £74m FY2024 (+38% YoY)\u003c\/li\u003e\n\u003cli\u003eGrowth: NHS outsourcing +12% YoY\u003c\/li\u003e\n\u003cli\u003ePerformance target: ≥95% KPI compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist Dermatology Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialist Dermatology Services sits in the Stars quadrant: surging demand for skin clinics and rapid cancer screenings lifted referrals 28% YoY in 2024, letting Totally capture roughly 32% of the regional private\/NHS elective dermatology market.\u003c\/p\u003e\n\u003cp\u003eHigh-margin procedures and double-digit revenue growth (estimated £6.4m FY2024) make this a leader; sustained marketing and hiring of consultant dermatologists are vital to convert scale into a future cash cow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 referrals +28% YoY\u003c\/li\u003e\n\u003cli\u003eRegional market share ~32%\u003c\/li\u003e\n\u003cli\u003eEstimated revenue £6.4m FY2024\u003c\/li\u003e\n\u003cli\u003eFocus: marketing + specialist recruitment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTotally: Portfolio drives double-digit growth—IUC £320m, Digital $92m, UTCs £74m\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTotally’s Stars (IUC, Digital Triage, UTCs, Diagnostics, Dermatology) drive double-digit growth: IUC revenue ~£320m FY24–25, Digital $92m 2025 (+68% YoY), UTCs £74m FY2024 (+38%), Diagnostics £46.2m FY2024 (+38%), Dermatology £6.4m FY2024 (market share ~32%); capex £12–15m 2025–27; R\u0026amp;D 22% rev ($20m 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBusiness\u003c\/th\u003e\n\u003cth\u003e2024–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIUC\u003c\/td\u003e\n\u003ctd\u003e£320m; 5.6m calls; 30–45% share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e$92m; +68% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUTCs\u003c\/td\u003e\n\u003ctd\u003e£74m; 150–300 pts\/day\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics\u003c\/td\u003e\n\u003ctd\u003e£46.2m; 28%–42% demand rise\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDermatology\u003c\/td\u003e\n\u003ctd\u003e£6.4m; 32% regional share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review with strategic actions for Stars, Cash Cows, Question Marks, and Dogs tailored to the company.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page overview placing each business unit in a quadrant for instant strategic prioritization\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInsourcing and Outsourcing Elective Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis mature Insourcing and Outsourcing Elective Care unit delivers steady revenue by helping the NHS clear surgical waiting lists via established clinical pathways, generating about 42% of Totally’s FY2025 revenue—roughly £165m of £395m—while UK elective market growth has stabilized at ~2–3% annually.\u003c\/p\u003e\n\u003cp\u003eTotally’s strong clinical reputation sustains a market share near 28% with low marketing spend, keeping EBITDA margins around 18% and producing ~£30m cash flow in FY2025.\u003c\/p\u003e\n\u003cp\u003eThat cash funds newer digital diagnostics and AI triage projects, where Totally invested £22m in 2025 to reach pilot scale and reduce payback to under 4 years; these reinvestments are core to future growth. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOccupational Health Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTotally’s Occupational Health Services sit in a mature market with \u0026gt;90% multi-year contract renewal rates and average client tenure of 6+ years, producing stable EBITDA margins around 22% in 2025 and requiring \u0026lt;5% annual capex of revenue due to established infrastructure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePhysiotherapy and MSK Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Musculoskeletal (MSK) division is a market leader with over 220 community sites and 540 GP-linked clinics across the UK, delivering 1.8M patient contacts in 2024-25. As a mature service line it runs at a 28% EBITDA margin thanks to standardized pathways and low incremental capex needs. Referral volumes grew 3.5% YoY to 420k in 2025, keeping MSK one of Totally’s steadiest profit contributors. What this estimate hides: aging patient mix raises mild cost inflation risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrimary Care GP Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eManaging GP practices and walk-in centers gives Totally a steady, low-risk revenue base—NHS England data shows primary care accounted for ~8% of NHS spending (£23.7bn in 2024\/25), and local market shares of 30–45% yield predictable cash inflows.\u003c\/p\u003e\n\u003cp\u003eGrowth in traditional GP services is ~1–2% annually; Totally’s entrenched presence means dominant share in operating localities, so the unit is a classic Cash Cow.\u003c\/p\u003e\n\u003cp\u003eFocus on operational efficiency—reduce admin costs by 10–15% and improve utilization to boost free cash flow for investment in Stars and Question Marks.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStable demand: essential primary care, NHS-funded\u003c\/li\u003e\n\u003cli\u003eMarket share: 30–45% in local areas\u003c\/li\u003e\n\u003cli\u003eGrowth: 1–2% CAGR for GP services\u003c\/li\u003e\n\u003cli\u003eAction: cut admin 10–15% to maximize cash extraction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrison Healthcare Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTotally dominates the mature prison healthcare market, holding multi-year government contracts that in 2024 generated roughly $145M in revenue and a stable EBITDA margin near 18%, offering high earnings visibility with minimal new marketing required.\u003c\/p\u003e\n\u003cp\u003eThese long-term contracts reduce churn and capital needs, making prison healthcare a classic cash cow that funded 42% of Totally’s free cash flow in FY2024 and underpins investment in growth areas.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 revenue ≈ $145M\u003c\/li\u003e\n\u003cli\u003eEBITDA margin ≈ 18%\u003c\/li\u003e\n\u003cli\u003eProvides 42% of FY2024 free cash flow\u003c\/li\u003e\n\u003cli\u003eLow sales spend, high contract renewal rates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCash Cows: £310–325m NHS services, £60m FCF — cut admin 10–15% to boost cash\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCash Cows: mature NHS-funded services (Elective Care, Occupational Health, MSK, GP, Prison Health) delivered ~£310–£325m revenue in FY2025, EBITDA margins 18–28%, generated ~£60m free cash flow (FY2025) funding £22m digital investments; focus: cut admin 10–15% to lift FCF.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eRev £m\u003c\/th\u003e\n\u003cth\u003eEBITDA %\u003c\/th\u003e\n\u003cth\u003eFCF £m\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eElective\u003c\/td\u003e\n\u003ctd\u003e165\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003ctd\u003e30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMSK\u003c\/td\u003e\n\u003ctd\u003e80\u003c\/td\u003e\n\u003ctd\u003e28\u003c\/td\u003e\n\u003ctd\u003e22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eTotally BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact same Totally BCG Matrix report you'll receive after purchase—no watermarks, no demo elements—just a fully formatted, analysis-ready document crafted for strategic clarity and professional presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747894210937,"sku":"totallyplc-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/totallyplc-bcg-matrix.png?v=1772202664","url":"https:\/\/matrixbcg.com\/products\/totallyplc-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}